| Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial U Menon, A Gentry-Maharaj, M Burnell, N Singh, A Ryan, C Karpinskyj, ... The Lancet 397 (10290), 2182-2193, 2021 | 584 | 2021 |
| Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort I Jacobs, A Gentry-Maharaj, M Burnell, R Manchanda, N Singh, A Sharma, ... The lancet oncology 12 (1), 38-48, 2011 | 294 | 2011 |
| The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome EJ Crosbie, NAJ Ryan, MJ Arends, T Bosse, J Burn, JM Cornes, ... Genetics in Medicine 21 (10), 2390-2400, 2019 | 235 | 2019 |
| Robotic-assisted vs traditional laparoscopic surgery for endometrial cancer: a randomized controlled trial MM Mäenpää, K Nieminen, EI Tomás, M Laurila, TH Luukkaala, ... American journal of obstetrics and gynecology 215 (5), 588. e1-588. e7, 2016 | 208 | 2016 |
| Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial R Manchanda, K Loggenberg, S Sanderson, M Burnell, J Wardle, ... Journal of the National Cancer Institute 107 (1), dju379, 2015 | 202 | 2015 |
| Evidence of stage shift in women diagnosed with ovarian cancer during phase II of the United Kingdom familial ovarian cancer screening study AN Rosenthal, LSM Fraser, S Philpott, R Manchanda, M Burnell, ... Journal of Clinical Oncology 35 (13), 1411-1420, 2017 | 199 | 2017 |
| Cost-effectiveness of population-based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 mutation testing in unselected general population women R Manchanda, S Patel, VS Gordeev, AC Antoniou, S Smith, A Lee, ... JNCI: Journal of the National Cancer Institute 110 (7), 714-725, 2018 | 198 | 2018 |
| Cost-effectiveness of population screening for BRCA mutations in Ashkenazi Jewish women compared with family history–based testing R Manchanda, R Legood, M Burnell, A McGuire, M Raikou, K Loggenberg, ... Journal of the National Cancer Institute 107 (1), dju380, 2015 | 195 | 2015 |
| Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule AN Rosenthal, L Fraser, R Manchanda, P Badman, S Philpott, J Mozersky, ... Journal of Clinical Oncology 31 (1), 49-57, 2013 | 177 | 2013 |
| Outcome of risk‐reducing salpingo‐oophorectomy in BRCA carriers and women of unknown mutation status R Manchanda, A Abdelraheim, M Johnson, AN Rosenthal, E Benjamin, ... BJOG: An International Journal of Obstetrics & Gynaecology 118 (7), 814-824, 2011 | 163 | 2011 |
| A cost-effectiveness analysis of multigene testing for all patients with breast cancer L Sun, A Brentnall, S Patel, DSM Buist, EJA Bowles, DGR Evans, ... JAMA oncology 5 (12), 1718-1730, 2019 | 139 | 2019 |
| Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: a systematic review and meta-analysis of individual patient data PA Cohen, A Powell, S Böhm, CB Gilks, CJR Stewart, TM Meniawy, ... Gynecologic oncology 154 (2), 441-448, 2019 | 109 | 2019 |
| Radiotherapy versus inguinofemoral lymphadenectomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: results of GROINSS-V II MHM Oonk, B Slomovitz, PJW Baldwin, HC Van Doorn, J Van der Velden, ... Journal of Clinical Oncology 39 (32), 3623-3632, 2021 | 107 | 2021 |
| Factors influencing uptake and timing of risk reducing salpingo‐oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis R Manchanda, M Burnell, A Abdelraheim, M Johnson, A Sharma, ... BJOG: An International Journal of Obstetrics & Gynaecology 119 (5), 527-536, 2012 | 81 | 2012 |
| Laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovary syndrome A Kriplani, R Manchanda, N Agarwal, B Nayar The Journal of the American Association of Gynecologic Laparoscopists 8 (4 …, 2001 | 80 | 2001 |
| Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry R Manchanda, S Patel, AC Antoniou, E Levy-Lahad, C Turnbull, ... American journal of obstetrics and gynecology 217 (5), 578. e1-578. e12, 2017 | 79 | 2017 |
| A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects S Jervis, H Song, A Lee, E Dicks, P Harrington, C Baynes, R Manchanda, ... Journal of Medical Genetics 52 (7), 465-475, 2015 | 78 | 2015 |
| Specifying the ovarian cancer risk threshold of ‘premenopausal risk-reducing salpingo-oophorectomy’for ovarian cancer prevention: a cost-effectiveness analysis R Manchanda, R Legood, AC Antoniou, VS Gordeev, U Menon Journal of medical genetics 53 (9), 591-599, 2016 | 75 | 2016 |
| Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems R Manchanda, L Sun, S Patel, O Evans, J Wilschut, AC De Freitas Lopes, ... Cancers 12 (7), 1929, 2020 | 69 | 2020 |
| Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC/Lynch syndrome (LS) R Manchanda, E Saridogan, A Abdelraheim, M Johnson, AN Rosenthal, ... Archives of gynecology and obstetrics 286, 1555-1562, 2012 | 68 | 2012 |
Professor Usha MenonMRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College在 ucl.ac.uk 的电子邮件经过验证
